CH EPL (R5)
0.1.0 - ci-build

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 20416

Generated Narrative: RegulatedAuthorization FOPH-20416

CH - EPL Reimbursement SL

  • FOPHDossierNumber: urn:oid:2.16.756.1/20416
  • status: Reimbursed
  • statusDate: 2023-01-01
  • expiryDate: 2025-03-31
  • listingStatus: Listed
  • listingPeriod: 2023-01-01 --> 2024-12-31
  • firstListingDate: 2017-09-01
  • costShare: 10
  • gamme: Parenteral Depot

CH - EPL Product Price

  • value: CHF4,407.68 (CHF)
  • type: Ex-factory price
  • changeType: Normal price mutation
  • changeDate: 2023-01-01

CH - EPL Product Price

  • value: CHF4,768.50 (CHF)
  • type: Retail price
  • changeType: VAT-change
  • changeDate: 2024-01-01

subject: PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7601001001138-6623101-001; description = KEYTRUDA Inf Konz 100 mg/4ml Durchstf

type: Reimbursement SL

Indications

-ExtensionReference
*ClinicalUseDefinition: type = indication

holder: Organization MSD Merck Sharp & Dohme AG

Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG

identifier: urn:oid:1.2.276.0.76/100080484, GLN/7601001001138

name: MSD Merck Sharp & Dohme AG